|
UBE2V2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.604830E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.427390E-01 |
| Normal-vs-Stage2 |
7.695600E-01 |
| Normal-vs-Stage3 |
3.300200E-01 |
| Normal-vs-Stage4 |
4.863400E-01 |
| Stage1-vs-Stage2 |
6.847800E-01 |
| Stage1-vs-Stage3 |
9.117800E-01 |
| Stage1-vs-Stage4 |
6.821400E-01 |
| Stage2-vs-Stage3 |
6.909400E-01 |
| Stage2-vs-Stage4 |
8.803200E-01 |
| Stage3-vs-Stage4 |
7.182400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.990250E-01 |
| Normal-vs-AfricanAmerican |
2.519800E-02 |
| Normal-vs-Asian |
8.147600E-01 |
| Caucasian-vs-AfricanAmerican |
1.804820E-01 |
| Caucasian-vs-Asian |
9.834200E-01 |
| AfricanAmerican-vs-Asian |
7.714600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.237800E-02 |
| Normal-vs-Female |
6.131000E-01 |
| Male-vs-Female |
2.705800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.022400E-02 |
| Normal-vs-Age(41-60Yrs) |
2.248000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.019400E-01 |
| Normal-vs-Age(81-100Yrs) |
6.969400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.039400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.608800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.068800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.708000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.802000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.389600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.184200E-01 |
| Normal-vs-Grade 2 |
8.997400E-01 |
| Normal-vs-Grade 3 |
1.535790E-02 |
| Normal-vs-Grade 4 |
2.191000E-01 |
| Grade 1-vs-Grade 2 |
4.717200E-01 |
| Grade 1-vs-Grade 3 |
5.649500E-02 |
| Grade 1-vs-Grade 4 |
2.417400E-01 |
| Grade 2-vs-Grade 3 |
3.450400E-02 |
| Grade 2-vs-Grade 4 |
3.027800E-01 |
| Grade 3-vs-Grade 4 |
5.219000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.201200E-01 |
| Normal-vs-ccB subtype |
2.194200E-01 |
| ccA subtype-vs-ccB subtype |
3.603000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.467000E-01 |
| Normal-vs-N1 |
2.469400E-01 |
| N0-vs-N1 |
7.334000E-01 |
|
|
